Cerner working with Elligo, Freenome on multiomics for early cancer detection

Cerner this week announced that it is collaborating with Elligo Health Research and Freenome for a clinical trial project that seeks to advance early cancer detection via insights derived from Cerner’s Learning Health Network.

WHY IT MATTERS
The three companies will be harness real-world data from the network’s participating health system and use Freenome’s “

” technology for the Sanderson Study, an forthcoming clinical trial designed…